Logo image of DUOT

DUOS TECHNOLOGIES GROUP INC (DUOT) Stock Fundamental Analysis

NASDAQ:DUOT - Nasdaq - US2660424076 - Common Stock - Currency: USD

6.42  -0.09 (-1.38%)

Fundamental Rating

1

Taking everything into account, DUOT scores 1 out of 10 in our fundamental rating. DUOT was compared to 284 industry peers in the Software industry. DUOT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, DUOT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DUOT had negative earnings in the past year.
DUOT had a negative operating cash flow in the past year.
DUOT had negative earnings in each of the past 5 years.
In the past 5 years DUOT always reported negative operating cash flow.
DUOT Yearly Net Income VS EBIT VS OCF VS FCFDUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -47.76%, DUOT is not doing good in the industry: 84.84% of the companies in the same industry are doing better.
DUOT has a worse Return On Equity (-418.67%) than 86.64% of its industry peers.
Industry RankSector Rank
ROA -47.76%
ROE -418.67%
ROIC N/A
ROA(3y)-67.78%
ROA(5y)-70.66%
ROE(3y)-383.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DUOT Yearly ROA, ROE, ROICDUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K 1.5K

1.3 Margins

The Gross Margin of DUOT (15.01%) is worse than 86.64% of its industry peers.
In the last couple of years the Gross Margin of DUOT has declined.
DUOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y80.38%
GM growth 5Y-16.5%
DUOT Yearly Profit, Operating, Gross MarginsDUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

DUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DUOT has been increased compared to 1 year ago.
DUOT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DUOT has an improved debt to assets ratio.
DUOT Yearly Shares OutstandingDUOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
DUOT Yearly Total Debt VS Total AssetsDUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

DUOT has an Altman-Z score of -4.26. This is a bad value and indicates that DUOT is not financially healthy and even has some risk of bankruptcy.
DUOT has a worse Altman-Z score (-4.26) than 84.12% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that DUOT is somewhat dependend on debt financing.
DUOT has a Debt to Equity ratio of 0.71. This is in the lower half of the industry: DUOT underperforms 71.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -4.26
ROIC/WACCN/A
WACC10.95%
DUOT Yearly LT Debt VS Equity VS FCFDUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.73 indicates that DUOT may have some problems paying its short term obligations.
With a Current ratio value of 0.73, DUOT is not doing good in the industry: 85.56% of the companies in the same industry are doing better.
A Quick Ratio of 0.56 indicates that DUOT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.56, DUOT is doing worse than 91.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.56
DUOT Yearly Current Assets VS Current LiabilitesDUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

DUOT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.26%.
The Revenue for DUOT has decreased by -38.12% in the past year. This is quite bad
Measured over the past years, DUOT shows a decrease in Revenue. The Revenue has been decreasing by -9.12% on average per year.
EPS 1Y (TTM)-16.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.1%
Revenue 1Y (TTM)-38.12%
Revenue growth 3Y-2.42%
Revenue growth 5Y-9.12%
Sales Q2Q%111.57%

3.2 Future

The Earnings Per Share is expected to grow by 29.18% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 72.75% on average over the next years. This is a very strong growth
EPS Next Y17.17%
EPS Next 2Y32.9%
EPS Next 3Y29.18%
EPS Next 5YN/A
Revenue Next Year-4.05%
Revenue Next 2Y65.03%
Revenue Next 3Y72.75%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DUOT Yearly Revenue VS EstimatesDUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
DUOT Yearly EPS VS EstimatesDUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DUOT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DUOT Price Earnings VS Forward Price EarningsDUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DUOT Per share dataDUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

DUOT's earnings are expected to grow with 29.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.9%
EPS Next 3Y29.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DUOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DUOS TECHNOLOGIES GROUP INC

NASDAQ:DUOT (2/4/2025, 8:00:01 PM)

6.42

-0.09 (-1.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)N/A N/A
Inst Owners28.05%
Inst Owner Change0.45%
Ins Owners26.42%
Ins Owner Change0.31%
Market Cap53.99M
Analysts82.5
Price Target8.93 (39.1%)
Short Float %0.53%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.83%
Min EPS beat(2)-27.75%
Max EPS beat(2)29.41%
EPS beat(4)2
Avg EPS beat(4)-17.23%
Min EPS beat(4)-72.55%
Max EPS beat(4)29.41%
EPS beat(8)4
Avg EPS beat(8)-20.3%
EPS beat(12)7
Avg EPS beat(12)-12.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.94%
Min Revenue beat(2)13.41%
Max Revenue beat(2)18.47%
Revenue beat(4)2
Avg Revenue beat(4)-10.82%
Min Revenue beat(4)-50.13%
Max Revenue beat(4)18.47%
Revenue beat(8)3
Avg Revenue beat(8)-15.73%
Revenue beat(12)5
Avg Revenue beat(12)-7.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)52.17%
EPS NQ rev (1m)-31.11%
EPS NQ rev (3m)-3050%
EPS NY rev (1m)-0.39%
EPS NY rev (3m)-10.87%
Revenue NQ rev (1m)-37.5%
Revenue NQ rev (3m)-68.21%
Revenue NY rev (1m)-12.74%
Revenue NY rev (3m)-29.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.35
P/FCF N/A
P/OCF N/A
P/B 21.49
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.43
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)-1.11
OCFYN/A
SpS0.87
BVpS0.3
TBVpS-0.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.76%
ROE -418.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.01%
FCFM N/A
ROA(3y)-67.78%
ROA(5y)-70.66%
ROE(3y)-383.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y80.38%
GM growth 5Y-16.5%
F-Score2
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 107.42%
Cap/Sales 23.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.56
Altman-Z -4.26
F-Score2
WACC10.95%
ROIC/WACCN/A
Cap/Depr(3y)192.7%
Cap/Depr(5y)166.43%
Cap/Sales(3y)8.52%
Cap/Sales(5y)6.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.1%
EPS Next Y17.17%
EPS Next 2Y32.9%
EPS Next 3Y29.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.12%
Revenue growth 3Y-2.42%
Revenue growth 5Y-9.12%
Sales Q2Q%111.57%
Revenue Next Year-4.05%
Revenue Next 2Y65.03%
Revenue Next 3Y72.75%
Revenue Next 5YN/A
EBIT growth 1Y-20.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.13%
EBIT Next 3Y37.12%
EBIT Next 5YN/A
FCF growth 1Y-98.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.61%
OCF growth 3YN/A
OCF growth 5YN/A